Eruptive Melanocytic Nevi in a Patient Undergoing Treatment With Sunitinib

被引：14

作者：

Jimenez-Gallo, David ^{[1
]}

Albarran-Planelles, Cristina ^{[1
]}

Linares-Barrios, Mario ^{[1
]}

Martinez-Rodriguez, Alberto ^{[1
]}

Maria Baez-Perea, Jose ^{[2
]}

机构：

[1] Puerta Mar Univ Hosp, Dept Dermatol, Cadiz 11009, Andalusia, Spain

[2] Puerta Mar Univ Hosp, Dept Pathol, Cadiz 11009, Andalusia, Spain

来源：

JAMA DERMATOLOGY | 2013年 / 149卷 / 05期

关键词：

SORAFENIB;

D O I：

10.1001/jamadermatol.2013.263

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

页码：624 / 626

页数：4

共 6 条

[1] Eruptive naevi associated with sorafenib treatment [J].

Bennani-Lahlou, M. ;

Mateus, C. ;

Escudier, B. ;

Massard, C. ;

Soria, J. -C. ;

Spatz, A. ;

Robert, C. .

ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2008, 135 (10) :672-674

[2]

Karram S, AM J DERMATOPATH, DOI [10.1097/DAD.0b013e31826db181, DOI 10.1097/DAD]

[3] Sorafenib-induced eruptive melanocytic lesions [J].

Kong, Heidi H. ;

Sibaud, Vincent ;

Turner, Maria L. Chanco ;

Fojo, Tito ;

Hornyak, Thomas J. ;

Chevreau, Christine .

ARCHIVES OF DERMATOLOGY, 2008, 144 (06) :820-822

[4] Cutaneous toxicities of the multikinase inhibitors sorafenib and sunitinib [J].

McLellan, Beth ;

Kerr, Holly .

DERMATOLOGIC THERAPY, 2011, 24 (04) :396-400

[5] BRAFE600-associated senescence-like cell cycle arrest of human naevi [J].

Michaloglou, C ;

Vredeveld, LCW ;

Soengas, MS ;

Denoyelle, C ;

Kuilman, T ;

van der Horst, CMAM ;

Majoor, DM ;

Shay, JW ;

Mooi, WJ ;

Peeper, DS .

NATURE, 2005, 436 (7051) :720-724

[6] Activation of the RAS/RAF/ERK Signaling Pathway Contributes to Resistance to Sunitinib in Thyroid Carcinoma Cell Lines [J].

Piscazzi, Annamaria ;

Costantino, Eleonora ;

Maddalena, Francesca ;

Natalicchio, Maria Iole ;

Gerardi, Assunta Maria Teresa ;

Antonetti, Raffaele ;

Cignarelli, Mauro ;

Landriscina, Matteo .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (06) :E898-E906

← 1 →